MICRONASE Drug Patent Profile
✉ Email this page to a colleague
When do Micronase patents expire, and when can generic versions of Micronase launch?
Micronase is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in MICRONASE is glyburide. There are twenty drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the glyburide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Micronase
A generic version of MICRONASE was approved as glyburide by TEVA on August 29th, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MICRONASE?
- What are the global sales for MICRONASE?
- What is Average Wholesale Price for MICRONASE?
Summary for MICRONASE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 152 |
Clinical Trials: | 6 |
Patent Applications: | 3,919 |
DailyMed Link: | MICRONASE at DailyMed |
Recent Clinical Trials for MICRONASE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Texas Tech University Health Sciences Center, El Paso | Early Phase 1 |
University of Maryland, College Park | Phase 1 |
University of Maryland | Phase 1 |
US Patents and Regulatory Information for MICRONASE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | MICRONASE | glyburide | TABLET;ORAL | 017498-001 | May 1, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | MICRONASE | glyburide | TABLET;ORAL | 017498-002 | May 1, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | MICRONASE | glyburide | TABLET;ORAL | 017498-003 | May 1, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MICRONASE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | MICRONASE | glyburide | TABLET;ORAL | 017498-003 | May 1, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | MICRONASE | glyburide | TABLET;ORAL | 017498-001 | May 1, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | MICRONASE | glyburide | TABLET;ORAL | 017498-001 | May 1, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | MICRONASE | glyburide | TABLET;ORAL | 017498-002 | May 1, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MICRONASE
See the table below for patents covering MICRONASE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Belgium | 684654 | ⤷ Sign Up | |
Brazil | 6685071 | ⤷ Sign Up | |
Austria | 275541 | ⤷ Sign Up | |
Monaco | 601 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |